Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features
Study Type: Treatment
Phase: III
NCTID: NCT05382338
Principal Investigator:
Keith August
Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma
Study Type: Treatment
Phase: II
NCTID: NCT03115333
Principal Investigator:
Tolga Tuncer
A Phase III Randomized, Placebo-Controlled Trial Evaluating Memantine IND 149832 for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors
Study Type: Supportive Care
Phase: III
NCTID: NCT04939597
Principal Investigator:
Keith August
Phase II Trial of Tremelimumab in Patients with Metastatic Urothelial Cancer Previously Treated with PD-1/PD-L1 Blockade
Laser Ablation of Abnormal Neurological Tissue using Robotic Neuroblate system LAANTERN Prospective Registry
Study Type: Other
Phase: N/A
NCTID: NCT02392078
Principal Investigator:
Patrick Landazuri
A Phase II Randomized Trial of Proton Vs. Photon Therapy IMRT For Cognitive Preservation in Patients with IDH Mutant, Low to Intermediate Grade Gliomas
A Randomized Phase II Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination with Atezolizumab Compared to Atezolizumab Alone in Subjects with Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where cisplatin-Based Treatment is Not an Option
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers ICONIC
Study Type: Treatment
Phase: II
NCTID: NCT03866382
Principal Investigator:
Elizabeth Wulff-Burchfield
PHASE III TRIAL OF SINGLE FRACTION STEREOTACTIC RADIOSURGERY SRS VERSUS FRACTIONATED SRS FSRS FOR INTACT BRAIN METASTASES
Study Type: Treatment
Phase: III
NCTID: NCT06500455
Principal Investigator:
Danielle Cunningham
A Multicenter Observational Study of GammaTileTM Surgically Targeted Radiation Therapy STaRT in Intracranial Brain Neoplasms
Study Type: Other
Phase: IV
NCTID: NCT04427384
Principal Investigator:
Roukoz Chamoun